Literature DB >> 25601932

Renal transporter activation during angiotensin-II hypertension is blunted in interferon-γ-/- and interleukin-17A-/- mice.

Nikhil V Kamat1, Salim R Thabet1, Liang Xiao1, Mohamed A Saleh1, Annet Kirabo1, Meena S Madhur1, Eric Delpire1, David G Harrison1, Alicia A McDonough2.   

Abstract

Ample genetic and physiological evidence establishes that renal salt handling is a critical regulator of blood pressure. Studies also establish a role for the immune system, T-cell infiltration, and immune cytokines in hypertension. This study aimed to connect immune cytokines, specifically interferon-γ (IFN-γ) and interleukin-17A (IL-17A), to sodium transporter regulation in the kidney during angiotensin-II (Ang-II) hypertension. C57BL/6J (wild-type) mice responded to Ang-II infusion (490 ng/kg per minute, 2 weeks) with a rise in blood pressure (170 mm Hg) and a significant decrease in the rate of excretion of a saline challenge. In comparison, mice that lacked the ability to produce either IFN-γ (IFN-γ(-/-)) or IL-17A (IL-17A(-/-)) exhibited a blunted rise in blood pressure (<150 mm Hg), and both the genotypes maintained baseline diuretic and natriuretic responses to a saline challenge. Along the distal nephron, Ang-II infusion increased abundance of the phosphorylated forms of the Na-K-2Cl cotransporter, Na-Cl cotransporter, and Ste20/SPS-1-related proline-alanine-rich kinase, in both the wild-type and the IL-17A(-/-) but not in IFN-γ(-/-) mice; epithelial Na channel abundance increased similarly in all the 3 genotypes. In the proximal nephron, Ang-II infusion significantly decreased abundance of Na/H-exchanger isoform 3 and the motor myosin VI in IL-17A(-/-) and IFN-γ(-/-), but not in wild-type; the Na-phosphate cotransporter decreased in all the 3 genotypes. Our results suggest that during Ang-II hypertension both IFN-γ and IL-17A production interfere with the pressure natriuretic decrease in proximal tubule sodium transport and that IFN-γ production is necessary to activate distal sodium reabsorption.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  NHE3 protein; NKCC2 protein sodium chloride cotransporters; SPAK protein; angiotensin-II; cytokines; epithelial Na+ channel

Mesh:

Substances:

Year:  2015        PMID: 25601932      PMCID: PMC4326622          DOI: 10.1161/HYPERTENSIONAHA.114.04975

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  42 in total

1.  Redistribution of myosin VI from top to base of proximal tubule microvilli during acute hypertension.

Authors:  Li E Yang; Arvid B Maunsbach; Patrick K K Leong; Alicia A McDonough
Journal:  J Am Soc Nephrol       Date:  2005-08-17       Impact factor: 10.121

2.  Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin II.

Authors:  Julian D Widder; Tomasz J Guzik; Cornelius F H Mueller; Roza E Clempus; Harald H H W Schmidt; Sergey I Dikalov; Kathy K Griendling; Dean P Jones; David G Harrison
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-02-01       Impact factor: 8.311

Review 3.  Mechanisms of proximal tubule sodium transport regulation that link extracellular fluid volume and blood pressure.

Authors:  Alicia A McDonough
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-01-27       Impact factor: 3.619

Review 4.  Renal inflammation, autoimmunity and salt-sensitive hypertension.

Authors:  Bernardo Rodríguez-Iturbe; Martha Franco; Edilia Tapia; Yasmir Quiroz; Richard J Johnson
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-01       Impact factor: 2.557

5.  Oligoclonal CD8+ T cells play a critical role in the development of hypertension.

Authors:  Daniel W Trott; Salim R Thabet; Annet Kirabo; Mohamed A Saleh; Hana Itani; Allison E Norlander; Jing Wu; Anna Goldstein; William J Arendshorst; Meena S Madhur; Wei Chen; Chung-I Li; Yu Shyr; David G Harrison
Journal:  Hypertension       Date:  2014-08-04       Impact factor: 10.190

6.  AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure.

Authors:  Susan B Gurley; Anne D M Riquier-Brison; Jurgen Schnermann; Matthew A Sparks; Andrew M Allen; Volker H Haase; John N Snouwaert; Thu H Le; Alicia A McDonough; Beverley H Koller; Thomas M Coffman
Journal:  Cell Metab       Date:  2011-04-06       Impact factor: 27.287

7.  Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension.

Authors:  Martha Franco; Flavio Martínez; Yasmir Quiroz; Othir Galicia; Rocio Bautista; Richard J Johnson; Bernardo Rodríguez-Iturbe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-05-02       Impact factor: 3.619

8.  Angiotensin II stimulates trafficking of NHE3, NaPi2, and associated proteins into the proximal tubule microvilli.

Authors:  Anne D M Riquier-Brison; Patrick K K Leong; Kaarina Pihakaski-Maunsbach; Alicia A McDonough
Journal:  Am J Physiol Renal Physiol       Date:  2009-10-28

9.  ANG II provokes acute trafficking of distal tubule Na+-Cl(-) cotransporter to apical membrane.

Authors:  Monica B Sandberg; Anne D M Riquier; Kaarina Pihakaski-Maunsbach; Alicia A McDonough; Arvid B Maunsbach
Journal:  Am J Physiol Renal Physiol       Date:  2007-05-16

10.  Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

Authors:  Meena S Madhur; Heinrich E Lob; Louise A McCann; Yoichiro Iwakura; Yelena Blinder; Tomasz J Guzik; David G Harrison
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190

View more
  95 in total

Review 1.  Immune Mechanisms in Arterial Hypertension.

Authors:  Ulrich Wenzel; Jan Eric Turner; Christian Krebs; Christian Kurts; David G Harrison; Heimo Ehmke
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

Review 2.  Inflammatory cytokines regulate renal sodium transporters: how, where, and why?

Authors:  Allison E Norlander; Meena S Madhur
Journal:  Am J Physiol Renal Physiol       Date:  2017-04-12

Review 3.  Role of immune cells in hypertension.

Authors:  Antoine Caillon; Pierre Paradis; Ernesto L Schiffrin
Journal:  Br J Pharmacol       Date:  2018-07-20       Impact factor: 8.739

4.  C-C Motif Chemokine Receptor 7 Exacerbates Hypertension Through Effects on T Lymphocyte Trafficking.

Authors:  Yi Wen; Nathan P Rudemiller; Jiandong Zhang; Xiaohan Lu; Jiafa Ren; Jamie R Privratsky; Robert Griffiths; Junyi J Zhang; Gianna E Hammer; Steven D Crowley
Journal:  Hypertension       Date:  2020-01-27       Impact factor: 10.190

5.  Salt Sensitivity in Response to Renal Injury Requires Renal Angiotensin-Converting Enzyme.

Authors:  Jorge F Giani; Kenneth E Bernstein; Tea Janjulia; Jiyang Han; Jorge E Toblli; Xiao Z Shen; Bernardo Rodriguez-Iturbe; Alicia A McDonough; Romer A Gonzalez-Villalobos
Journal:  Hypertension       Date:  2015-07-06       Impact factor: 10.190

6.  Renal Denervation Prevents Immune Cell Activation and Renal Inflammation in Angiotensin II-Induced Hypertension.

Authors:  Liang Xiao; Annet Kirabo; Jing Wu; Mohamed A Saleh; Linjue Zhu; Feng Wang; Takamune Takahashi; Roxana Loperena; Jason D Foss; Raymond L Mernaugh; Wei Chen; Jackson Roberts; John W Osborn; Hana A Itani; David G Harrison
Journal:  Circ Res       Date:  2015-07-08       Impact factor: 17.367

Review 7.  The WNK signaling pathway and salt-sensitive hypertension.

Authors:  Taisuke Furusho; Shinichi Uchida; Eisei Sohara
Journal:  Hypertens Res       Date:  2020-04-14       Impact factor: 3.872

Review 8.  Inflammation, immunity, and hypertensive end-organ damage.

Authors:  William G McMaster; Annet Kirabo; Meena S Madhur; David G Harrison
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

Review 9.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

10.  Skin tight: macrophage-specific COX-2 induction links salt handling in kidney and skin.

Authors:  Johannes Stegbauer; Thomas M Coffman
Journal:  J Clin Invest       Date:  2015-10-20       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.